Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vorinostat in newly diagnosed breast cancer
NCT00262834Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Oct 2005
- Primary completion
- Oct 2008
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vorinostat in breast cancer, sponsored by National Cancer Institute. Started Oct 2005; status: completed.
02
Drugs
vorinostat
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00262834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00262834.